Evidence map›Paper›PMID 41180837›Full record

ReviewFrontiers in bioengineering and biotechnology2025

Bioscaffold materials resist infection and promote bone defect repair by regulating neutrophil function.

Jingyu Zhou, Shilang Xiong, Shiwei Liu, Zhigang Zhou, Min Liu, Hanrui Xi, Weihao Kong, Jianguo Zhou, Long Xiong

Abstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jingyu Zhou *Department of Orthopedics, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Shilang Xiong *Department of Orthopedics, Tenth People's Hospital of Tongji University, Shanghai, China.
Shiwei Liu *Department of Joint Surgery, Ganzhou People's Hospital, Ganzhou, China.
Zhigang ZhouDepartment of Orthopedics, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Min LiuDepartment of Orthopedics, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Hanrui XiDepartment of Orthopedics, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Weihao KongDepartment of Joint Surgery, Ganzhou People's Hospital, Ganzhou, China.
Jianguo ZhouDepartment of Joint Surgery, Ganzhou People's Hospital, Ganzhou, China.
Long XiongDepartment of Orthopedics, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infectious bone defects frequently encounter challenges related to bacterial infection and bone integrity. Neutrophils, being the initial responders to sites of inflammation, employ multiple mechanisms to eradicate bacteria, including phagocytosis, degranulation, the formation of neutrophil extracellular traps (NETs), and the oxidative respiratory burst. As a critical component of the human immune system, neutrophils play a pivotal role in modulating the inflammatory response, influencing the processes of osteogenesis and osteoclastogenesis, and impacting fracture healing. In the field of bone tissue engineering, the optimization of the chemical composition and morphology of scaffold materials can effectively modulate neutrophil behavior, thereby enhancing the antibacterial properties and osteogenic potential of the scaffolds. These approaches offer innovative strategies for designing bone tissue engineering scaffolds capable of regulating immune responses, with the potential to achieve improved clinical outcomes in future therapeutic applications.

Indexed as

antibacterialbone tissue engineeringneutrophilsosteogenicscaffolds

Identifiers

PMID41180837
PMCPMC12571867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.